Activation of the Receptor for Advanced Glycation End Products System in Women with Severe Preeclampsia | Zendy

Emily A. Oliver | Zendy; Catalin S. Buhimschi | Zendy; Antonette T. Dulay | Zendy; Margaret A. Baumbusch | Zendy; Sonya S. AbdelRazeq | Zendy; Sarah Y. Lee | Zendy; Guomao Zhao | Zendy; Shichu Jing | Zendy; Christian M. Pettker | Zendy; Irina A. Buhimschi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Activation of the Receptor for Advanced Glycation End Products System in Women with Severe Preeclampsia

Author(s) -

Emily A. Oliver,

Catalin S. Buhimschi,

Antonette T. Dulay,

Margaret A. Baumbusch,

Sonya S. AbdelRazeq,

Sarah Y. Lee,

Guomao Zhao,

Shichu Jing,

Christian M. Pettker,

Irina A. Buhimschi

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2010-1418

Subject(s) - amniotic fluid , glycation , medicine , endocrinology , rage (emotion) , preeclampsia , placenta , biology , cord blood , xanthine oxidase , amnion , receptor , andrology , fetus , pregnancy , biochemistry , enzyme , genetics , neuroscience

Activation of the receptor for advanced glycation end products (RAGE) mediates cellular injury. Soluble forms of RAGE [soluble RAGE (sRAGE), endogenous secretory (esRAGE)] bind RAGE ligands, thereby preventing downstream signaling and damage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research